Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
Authors
Keywords
Vitamin C, Oxidation, Iron, Oxidation-reduction reactions, Cancer treatment, Chelation, Nitrogen, Quinolines
Journal
PLoS One
Volume 9, Issue 10, Pages e110291
Publisher
Public Library of Science (PLoS)
Online
2014-10-21
DOI
10.1371/journal.pone.0110291
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prion-like aggregation of mutant p53 in cancer
- (2014) Jerson L. Silva et al. TRENDS IN BIOCHEMICAL SCIENCES
- Iron Chelators in Photodynamic Therapy Revisited: Synergistic Effect by Novel Highly Active Thiosemicarbazones
- (2014) Anna Mrozek-Wilczkiewicz et al. ACS Medicinal Chemistry Letters
- Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers
- (2013) Charles A. Kunos et al. GYNECOLOGIC ONCOLOGY
- Alkyl Substituted 2′-Benzoylpyridine Thiosemicarbazone Chelators with Potent and Selective Anti-Neoplastic Activity: Novel Ligands that Limit Methemoglobin Formation
- (2013) Christian Stefani et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Iron-Regulated Metastasis Suppressor NDRG1 Targets NEDD4L, PTEN, and SMAD4 and Inhibits the PI3K and Ras Signaling Pathways
- (2012) Zaklina Kovacevic et al. ANTIOXIDANTS & REDOX SIGNALING
- Novel Chelators for Cancer Treatment: Where Are We Now?
- (2012) Angelica M. Merlot et al. ANTIOXIDANTS & REDOX SIGNALING
- Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy
- (2012) Maciej Serda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and biological evaluation of substituted 2-benzoylpyridine thiosemicarbazones: Novel structure–activity relationships underpinning their anti-proliferative and chelation efficacy
- (2012) Adeline Y. Lukmantara et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo
- (2012) David B. Lovejoy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study
- (2012) Charles Kunos et al. Journal of Translational Medicine
- Investigation of the Biological Properties of (Hetero)Aromatic Thiosemicarbazones
- (2012) Maciej Serda et al. MOLECULES
- Finding the sweet spot: the role of nature and nurture in medicinal chemistry
- (2012) Michael M. Hann et al. NATURE REVIEWS DRUG DISCOVERY
- Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy
- (2011) Y Yu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes
- (2011) D. B. Lovejoy et al. CANCER RESEARCH
- The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms
- (2011) Zaklina Kovacevic et al. CARCINOGENESIS
- Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
- (2011) Nicholas A. Meanwell CHEMICAL RESEARCH IN TOXICOLOGY
- Halogenated 2′-Benzoylpyridine Thiosemicarbazone (XBpT) Chelators with Potent and Selective Anti-Neoplastic Activity: Relationship to Intracellular Redox Activity
- (2011) Christian Stefani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and c-Met Kinase Inhibition of 3,5-Disubstituted and 3,5,7-Trisubstituted Quinolines: Identification of 3-(4-Acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a Novel Anticancer Agent
- (2011) Yuanxiang Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic Cancer
- (2011) Z. Kovacevic et al. MOLECULAR PHARMACOLOGY
- Molecular obesity, potency and other addictions in drug discovery
- (2011) Michael M. Hann MedChemComm
- Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity
- (2010) Bhadaliya Chetan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
- (2010) Allyson J. Ocean et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) for Locally Advanced Cervical Cancer
- (2010) C. A. Kunos et al. CLINICAL CANCER RESEARCH
- Zinc(II) complexes of 2-acetyl pyridine 1-(4-fluorophenyl)-piperazinyl thiosemicarbazone: Synthesis, spectroscopic study and crystal structures – Potential anticancer drugs
- (2010) Tatjana P. Stanojkovic et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
- (2009) C. M. Nutting et al. ANNALS OF ONCOLOGY
- Inhibitory mechanisms of heterocyclic carboxaldehyde thiosemicabazones for two forms of human ribonucleotide reductase
- (2009) Lijun Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin
- (2009) K. Yu et al. CANCER RESEARCH
- 2-Acetylpyridine Thiosemicarbazones are Potent Iron Chelators and Antiproliferative Agents: Redox Activity, Iron Complexation and Characterization of their Antitumor Activity
- (2009) Des R. Richardson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors
- (2009) Yu Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Novel Iron Chelator, 2-Pyridylcarboxaldehyde 2-Thiophenecarboxyl Hydrazone, Reduces Catecholamine-Mediated Myocardial Toxicity
- (2008) Pr̆emysl Mladĕnka et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia
- (2008) Olatoyosi M. Odenike et al. INVESTIGATIONAL NEW DRUGS
- Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
- (2008) M. Paul Gleeson JOURNAL OF MEDICINAL CHEMISTRY
- Iron Chelators of the Dipyridylketone Thiosemicarbazone Class: Precomplexation and Transmetalation Effects on Anticancer Activity
- (2008) Paul V. Bernhardt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationships of Novel Iron Chelators for the Treatment of Iron Overload Disease: The Methyl Pyrazinylketone Isonicotinoyl Hydrazone Series
- (2007) Danuta S. Kalinowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders
- (2007) Judith E. Karp et al. LEUKEMIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started